Glaucoma report points to increased costs

June 4, 2008,

A new Centre for Eye Research Australia/ Access Economics report shows the cost of glaucoma will more than double in the next two decades.

'Tunnel Vision: the Economic Impact of Primary Open Angle Glaucoma', shows associated healthcare costs totaled $1.9 billion in 2005 and costs are expected to climb to $4.3 billion per annum by 2025, if no changes are made to current practices.

Glaucoma damages the optic nerve, connecting the brain to the eyes, and is the world's leading cause of irreversible blindness. Current treatments can slow the progression of the disease but cannot reverse the damage caused.

The report recommends:

-- A public health awareness campaign to help increase in the rate of diagnosis by people at higher risk of glaucoma (especially family history) and educating eye care practitioners;

-- An up-to-date study to compare effectiveness of initial laser treatment with glaucoma medication;

-- The development of new treatments that can further reduce glaucoma progression rates by 50% over and above current therapy.

Professor Jonathan Crowston, head of Centre for Eye Research Australia¡¦s Glaucoma Research Unit, said about 300,000 Australians have glaucoma yet half of these are unaware they have a potentially blinding condition. As Australians live longer, the number of people developing glaucoma is increasing. Around 1 in 10 people over the age of 80 has glaucoma.

"There is good evidence to suggest that glaucoma runs in families and for that reason we strongly recommend people to see an eye care specialist if family members have been diagnosed with glaucoma," Professor Crowston said. In general people over the age of 40 should have their eyes checked at least every two years.

Among a number of studies, the Glaucoma Research Unit is investigating what makes older optic nerve cells more prone to damage, in order to identify therapeutic targets to protect vision.

Source: Research Australia

Explore further: A new class of drug to treat herpes simplex virus-1 infection

Related Stories

A new class of drug to treat herpes simplex virus-1 infection

February 14, 2018
For patients with the herpes simplex-1 virus (HSV-1), there are just a handful of drugs available to treat the painful condition that can affect the eyes, mouth and genitals.

Study finds genetic link between thinner corneas and increased risk of glaucoma

January 25, 2018
Genetic studies in mice point to a protein called POU6F2, which can modulate corneal thickness, as a possible risk factor for glaucoma in humans, report Eldon Geisert of Emory University, and colleagues, January 25th in PLOS ...

Most glaucoma patients don't ask about medication costs

December 2, 2017
Less than one-third of patients with glaucoma talk to their doctor about the costs of medications needed to control their disease, reports a study in the December issue of Optometry and Vision Science, the official journal ...

Glaucoma patients report a wide range of emotional and psychological changes

April 11, 2011
Fear of the unknown is one of the greatest issues facing patients with glaucoma - the second leading cause of blindness worldwide after cataracts - according to research in the April issue of the Journal of Advanced Nursing. ...

Researcher explores best treatments for glaucoma

November 17, 2016
Researchers at Queen's University Belfast together with University of St Andrews and Aberdeen have found that the procedure used to remove cataracts is more successful than current standard treatments with laser in treating ...

Study in mice suggests stem cells could ward off glaucoma

July 26, 2016
An infusion of stem cells could help restore proper drainage for fluid-clogged eyes at risk for glaucoma. That's the upshot of a study led by a Veterans Affairs and University of Iowa team.

Recommended for you

Ambitious global virome project could mark end of pandemic era

February 23, 2018
Rather than wait for viruses like Ebola, SARS and Zika to become outbreaks that force the world to react, a new global initiative seeks to proactively identify, prepare for and stop viral threats before they become pandemics.

Forecasting antibiotic resistance with a 'weather map' of local data

February 23, 2018
The resistance that infectious microbes have to antibiotics makes it difficult for physicians to confidently select the right drug to treat an infection. And that resistance is dynamic: It changes from year to year and varies ...

Study reveals how kidney disease happens

February 22, 2018
Monash researchers have solved a mystery, revealing how certain immune cells work together to instigate autoimmune kidney disease.

Scientists gain new insight on how antibodies interact with widespread respiratory virus

February 22, 2018
Scientists have found and characterized the activity of four antibodies produced by the human immune system that target an important protein found in respiratory syncytial virus (RSV), according to new research published ...

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.